Narciso Thad Padua, MD
Pediatrics · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Padua’s office at (408) 947-2929 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A45172 · Current
Licensed to practise in California · since 1988 · expires 2027-10-31 · Far Eastern University, Dr. Nicanor Reyes Medical Foundation.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$140,791 in 2024
Medicaid paid $140,791 for 1,794 billed services this clinician did in 2024, up to 69 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 662 | $139,572 |
| Short return visit (20+ min) | 484 | $854 |
| Pure tone audiometry (threshold); air only | 153 | $166 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 42 | $149 |
| Short return visit | 151 | $52 |
| Bilateral quantitative screening test of visual acuity | 148 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 46 | $0 |
| Screening performed and negative | 108 | $0 |
| 2024 | 1,794 | 8 | 69 | $140,791 |
| 2023 | 2,114 | 13 | 82 | $148,037 |
| 2022 | 2,145 | 10 | 77 | $118,803 |
| 2021 | 9,395 | 28 | 252 | $590,209 |
| 2020 | 13,334 | 35 | 315 | $606,454 |
| 2019 | 14,496 | 33 | 380 | $579,127 |
| 2018 | 9,745 | 21 | 414 | $460,005 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 702 | $141,524 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 78 | $1,595 |
| Pure tone audiometry (threshold); air only | 192 | $1,452 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 60 | $1,390 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 146 | $784 |
| Screening performed and negative | 143 | $580 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 27 | $536 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 19 | $110 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 18 | $42 |
| Short return visit (20+ min) | 486 | $24 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 29 | $0 |
| Bilateral quantitative screening test of visual acuity | 109 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 584 | $112,302 |
| Pure tone audiometry (threshold); air only | 297 | $2,133 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 63 | $1,278 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 40 | $967 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 29 | $725 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 172 | $704 |
| Short return visit (20+ min) | 289 | $567 |
| Short return visit | 276 | $98 |
| Screening performed and negative | 243 | $29 |
| Bilateral quantitative screening test of visual acuity | 152 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 2,302 | $553,344 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 567 | $7,832 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 460 | $6,305 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 335 | $5,221 |
| Pure tone audiometry (threshold); air only | 618 | $3,965 |
| Developmental screening | 101 | $2,280 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 95 | $1,995 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 440 | $1,786 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 356 | $1,409 |
| Short return visit | 1,513 | $1,260 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 281 | $1,121 |
| Short return visit (20+ min) | 763 | $813 |
2020
| Clinic visit/encounter, all-inclusive | 3,028 | $560,882 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 599 | $8,491 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 559 | $7,453 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 492 | $7,203 |
| Pure tone audiometry (threshold); air only | 885 | $5,509 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 229 | $4,534 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 451 | $2,202 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 492 | $1,934 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 399 | $1,538 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 349 | $1,359 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 248 | $1,210 |
| Hepatitis B vaccine (HepB), pediatric/adolescent dosage, 3 dose schedule, for intramuscular use | 257 | $972 |
2019
| Clinic visit/encounter, all-inclusive | 4,247 | $505,342 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 700 | $14,963 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 467 | $12,375 |
| Pure tone audiometry (threshold); air only | 1,171 | $11,328 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 492 | $9,716 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 265 | $8,282 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 821 | $4,176 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 442 | $2,510 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 336 | $1,845 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 236 | $1,339 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 231 | $1,032 |
| Developmental screening | 26 | $1,020 |
2018
| Clinic visit/encounter, all-inclusive | 3,972 | $417,596 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 291 | $8,460 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 473 | $7,914 |
| Pure tone audiometry (threshold); air only | 764 | $7,582 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 323 | $5,546 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 111 | $5,501 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 600 | $3,219 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 287 | $1,349 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 214 | $1,012 |
| Hepatitis B vaccine (HepB), pediatric/adolescent dosage, 3 dose schedule, for intramuscular use | 118 | $556 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 89 | $436 |
| Rotavirus vaccine, human, attenuated (RV1), 2 dose schedule, live, for oral use | 73 | $337 |
Money from drug and device companies
$178 in 2025
| 2025 | 1 | 2 | None | $178 |
| 2019 | 1 | 1 | None | $12 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sanofi-Aventis U.S. | Tzield | $178 | 2 payments
|
See all 2 published payments
| Sanofi-Aventis U.S. | Meals · 2025-03-19 | Tzield | $150 |
| Sanofi-Aventis U.S. | Meals · 2025-02-26 | Tzield | $28 |
See earlier years (2019)
2019: $12
| Sanofi Pasteur | Pentacel | $12 | 1 payment
|
Professional record
- NPI
- 1235184219
- Licence
- CA A45172California A45172: Current · expires 2027-10-31
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A451720
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 2039 Forest Ave, Suite 304, San Jose, CA, 95128
- NPI first listed
- 2006-05-24
- NPI last updated
- 2013-05-08
This is when the NPI record was last certified, not a medical board exam.